Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 2.55 AED
Change Today +0.02 / 0.79%
Volume 4.4K
JULPHAR On Other Exchanges
Abu Dhabi
As of 6:00 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

gulf pharmaceutical industri (JULPHAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/6/14 - 3.09
52 Week Low
05/27/15 - 2.38
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

gulf pharmaceutical industri (JULPHAR) Related Businessweek News

No Related Businessweek News Found

gulf pharmaceutical industri (JULPHAR) Details

Gulf Pharmaceutical Industries P.S.C. manufactures and sells medicines, drugs, and other pharmaceutical and medical compounds in the United Arab Emirates and internationally. The company provides products that target various therapeutic segments, including antibiotics, biotech, cardiovascular, dermatology, GIT, insulin, metabolic, over the counter, paramedical, pulmonary, women’s health, and wound and burn. It also offers cosmetic compounds; wrapping and packing materials; and transportation services. The company was founded in 1980 and is based in Ras Al Khaimah, the United Arab Emirates.

Founded in 1980

gulf pharmaceutical industri (JULPHAR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gulf pharmaceutical industri (JULPHAR) Key Developments

Gulf Pharmaceutical Industries P.S.C., Board Meeting, Jun 04, 2015

Gulf Pharmaceutical Industries P.S.C., Board Meeting, Jun 04, 2015., at 11:30 Indian Standard Time. Agenda: To approve the Minutes of board meeting; to consider Julphar Diabetes updates; and to consider any new business.

Gulf Pharmaceutical Industries P.S.C. Approves Cash Dividend for the Year 2014

The Shareholders' of Gulf Pharmaceutical Industries P.S.C. ordinary general assembly held on 30 April 2015 approved the payment of cash dividends at 15% of share capital amounting to AED 150 million and issuance of bonus shares at 5% of share capital amounting to AED 50 million for the year 2014 (2014: the Shareholders general assembly approved cash dividends at 10% of share capital amounting to AED 86,315,535 and bonus shares at 10% of share capital amounting to AED 86,315,535 for the year 2013).

Gulf Pharmaceutical Industries P.S.C. Reports Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Gulf Pharmaceutical Industries P.S.C. reported consolidated unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported sales of AED 397,599,000 against AED 393,458,000 a year ago. Profit for the period attributable to equity holders of the company was AED 60,490,000 or 6.0 fils per basic share against AED 70,623,000 or 7.4 fils per basic share a year ago. Net cash used in operating activities was AED 18,368,000 against AED 74,529,000 a year ago. Additions to property, plant and equipment were AED 11,798,000 against AED 19,668,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JULPHAR:UH 2.55 AED +0.02

JULPHAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JULPHAR.
View Industry Companies

Industry Analysis


Industry Average

Valuation JULPHAR Industry Range
Price/Earnings 11.7x
Price/Sales 1.9x
Price/Book 1.2x
Price/Cash Flow 11.9x
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GULF PHARMACEUTICAL INDUSTRI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at